Hengbo Pharma appoints Zhang Baohong as President of the Metabolism Division.

On August 6, Hepalink announced the appointment of Zhang Baohong as the president of the Metabolism Division. Zhang Baohong will be based in Shanghai and will report directly to Wang Jinsong, the founder, chairman, and CEO of Hepalink. As the president of the Metabolism Division, Zhang Baohong will be fully responsible for the strategic formulation and daily operations of the division, overseeing pipeline layout, research and development advancement, organizational development, strategic partnerships, and NewCo incubation, among other tasks, to accelerate the delivery of transformative therapeutic solutions to patients.